Orna Therapeutics
Orna Therapeutics develops innovative methods and drugs in the field of RNA therapeutics. The firm plans to use its products to help treat various kinds of diseases.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
- Combo news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Investors
Merck
MPM CapitalNews related to Orna Therapeutics
Orna Therapeutics • 5 Jan 2023Simnova and Orna Therapeutics Collaborate to Advance Orna's ...
Simnova and Orna Therapeutics Collaborate to Advance Orna's Next Generation Circular RNA Technology in China ...
https://www.prnewswire.com/news-releases/simnova-and-orna-therapeutics-collaborate-to-advance-ornas-next-generation-circular-rna-technology-in-china-301714094.htmlOrna Therapeutics • 16 Aug 2022BioImpact Capital Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer
BioImpact Capital, an affiliate of MPM Capital ("MPM"), announced today that Orna Therapeutics ...
https://www.benzinga.com/pressreleases/22/08/b28512887/bioimpact-capital-announces-a-multi-billion-dollar-landmark-transaction-in-vaccines-and-cancer